XML 24 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814
Loss per Share (Tables)
 9 Months Ended
Sep. 30, 2015
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Loss Per Share
The following table sets forth the computation of basic and diluted loss per share for the three and nine months ended September 30, 2015 and 2014:

 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2015
 
2014
 
2015
 
2014
 
(in thousands, except per share amounts)
Basic and diluted
 
 
 
 
 
 
 
Net loss attributable to The Medicines Company
$
(105,132
)
 
$
(16,736
)
 
$
(146,690
)
 
$
(26,889
)
 
 
 
 
 
 
 
 
Weighted average common shares outstanding, basic
67,137

 
64,534

 
66,079

 
64,363

Plus: net effect of dilutive stock options, restricted common shares and shares issuable upon conversion of convertible senior notes due 2017
—

 
—

 
—

 
—

Weighted average common shares outstanding, diluted
67,137

 
64,534

 
66,079

 
64,363

 
 
 
 
 
 
 
 
Loss per share attributable to The Medicines Company, basic
$
(1.57
)
 
$
(0.26
)
 
$
(2.22
)
 
$
(0.42
)
Loss per share attributable to The Medicines Company, diluted
$
(1.57
)
 
$
(0.26
)
 
$
(2.22
)
 
$
(0.42
)